{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:34:56Z","timestamp":1791984896776,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recent studies suggest a contribution of intrahepatic mineralocorticoid receptor (MR) activation to the development of cirrhosis. As MR blockade abrogates the development of cirrhosis and hypoxia, common during the development of cirrhosis, can activate MR in hepatocytes. But, the impact of non-physiological hepatic MR activation is unknown. In this study, we investigate the impact of hypoxia-induced hepatocyte MR activation as a relevant factor in cirrhosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>RNA sequencing followed by gene ontology term enrichment analysis was performed on liver samples from rats treated for 12 weeks with or without CCl<jats:sub>4<\/jats:sub> and for the last four weeks with or without eplerenone (MR antagonist). We investigated if these changes can be mimicked by hypoxia in a human hepatocyte cell line (HepG2 cells) and in primary rat hepatocytes (pRH). In order to evaluate the functional cellular importance, hepatocyte lipid accumulation, glucose consumption, lactate production and mitochondrial function were analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In cirrhotic liver tissue genes annotated to the GOterm \u201cMonocarboxylic acid metabolic process\u201d (PPAR\u03b1, PDK4, AMACR, ABCC2, Lipin1) are downregulated. This effect is reversed by the MR antagonist eplerenone in vivo. The alterations are partially mimicked by hypoxia in rat and human hepatocytes in tissue culture. Furthermore, the reduction of mRNA and protein expression of PPAR\u03b1, PDK4, AMACR, ABCC2 and Lipin1 during hypoxia is prevented by eplerenone in rat and human hepatocytes. Aldosterone, the endogenous MR agonist, did not affect the expression of those proteins in hepatocytes. As those proteins are key regulators of hepatocyte energy homeostasis, we analyzed if hypoxia affected glucose consumption, lactate production and lipid accumulation in HepG2 cells in a MR-mediated manner. All three parameters were affected by hypoxia and were partially normalized by eplerenone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our findings suggest that non-physiological MR activation plays a role in the dysregulation of glucose and lipid metabolism in hepatocytes. This leads to an increase in apoptosis, probably resulting in a proinflammatory micromilieu of the hepatic tissue. The enhanced deposition of extracellular matrix contributes to the development of cirrhosis. Therefore, MR antagonists may have therapeutic potential in the treatment of early stages of liver disease due to their direct action in the liver.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12964-024-01991-2","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T11:13:52Z","timestamp":1734693232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism"],"prefix":"10.1186","volume":"22","author":[{"given":"Mohammad Mohabbulla","family":"Mohib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindy","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nolze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quratul","family":"Ain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zipprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gekle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schreier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"issue":"1","key":"1991_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"key":"1991_CR2","doi-asserted-by":"crossref","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023; 79(2):516\u201337. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168827823001940","DOI":"10.1016\/j.jhep.2023.03.017"},{"key":"1991_CR3","doi-asserted-by":"crossref","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sol\u00e0 E, Fabrellas N, Kamath PS. Liver cirrhosis. The Lancet. 2021; 398(10308):1359\u201376. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S014067362101374X","DOI":"10.1016\/S0140-6736(21)01374-X"},{"key":"1991_CR4","doi-asserted-by":"crossref","unstructured":"Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Molecular Aspects of Medicine. 2019; 65:37\u201355. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0098299718300700","DOI":"10.1016\/j.mam.2018.09.002"},{"key":"1991_CR5","doi-asserted-by":"crossref","unstructured":"Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: Concept to treatment. J Hepatol. 2015; 62(1, Supplement):S15-S24. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S016882781500149X","DOI":"10.1016\/j.jhep.2015.02.039"},{"issue":"5","key":"1991_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jcmgh.2015.06.011","volume":"1","author":"C Bocca","year":"2015","unstructured":"Bocca C, Novo E, Miglietta A, Parola M. Angiogenesis and Fibrogenesis in Chronic Liver diseases. Cell Mol Gastroenterol Hepatol. 2015;1(5):477\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"1991_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743\u201352.","journal-title":"J Hepatol"},{"key":"1991_CR8","unstructured":"de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Abraldes JG et al. Baveno VII \u2013 Renewing consensus in portal hypertension. J Hepatol. 2022; 76(4):959\u201374. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168827821022996"},{"issue":"12","key":"1991_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1365-2362.2008.02044.x","volume":"38","author":"JJ Kuiper","year":"2008","unstructured":"Kuiper JJ, Boomsma F, van Buren H, de Man R, Danser AHJ, van den Meiracker AH. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. Eur J Clin Invest. 2008;38(12):939\u201344.","journal-title":"Eur J Clin Invest"},{"key":"1991_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.steroids.2013.10.016","volume":"81","author":"M Gekle","year":"2014","unstructured":"Gekle M, Bretschneider M, Meinel S, Ruhs S, Grossmann C. Rapid mineralocorticoid receptor trafficking. Steroids. 2014;81:103\u20138.","journal-title":"Steroids"},{"issue":"1\u20132","key":"1991_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","volume":"308","author":"C Grossmann","year":"2009","unstructured":"Grossmann C, Gekle M. New aspects of rapid aldosterone signaling. Mol Cell Endocrinol. 2009;308(1\u20132):53\u201362.","journal-title":"Mol Cell Endocrinol"},{"key":"1991_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.steroids.2014.05.017","volume":"91","author":"S Meinel","year":"2014","unstructured":"Meinel S, Gekle M, Grossmann C. Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators. Steroids. 2014;91:3\u201310.","journal-title":"Steroids"},{"issue":"11","key":"1991_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1291\/hypres.28.925","volume":"28","author":"S Nakano","year":"2005","unstructured":"Nakano S, Kobayashi N, Yoshida K, Ohno T, Matsuoka H. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme\/epidermal growth factor receptor\/extracellular signal-regulated kinases, NAD(P)H oxidase\/lectin-like oxidized low-density lipoprotein receptor-1, and rho-kinase pathways in aldosterone\/salt-induced hypertensive rats. Hypertens Res. 2005;28(11):925\u201336.","journal-title":"Hypertens Res"},{"issue":"2","key":"1991_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mce.2011.07.045","volume":"350","author":"C Grossmann","year":"2012","unstructured":"Grossmann C, Gekle M. Interaction between mineralocorticoid receptor and epidermal growth factor receptor signaling. Mol Cell Endocrinol. 2012;350(2):235\u201341.","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"1991_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/liv.12794","volume":"35","author":"M Pizarro","year":"2015","unstructured":"Pizarro M, Sol\u00eds N, Quintero P, Barrera F, Cabrera D, Rojas-de Santiago P, et al. Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis. Liver Int. 2015;35(9):2129\u201338.","journal-title":"Liver Int"},{"issue":"14","key":"1991_CR16","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1111\/bph.14341","volume":"175","author":"B Schreier","year":"2018","unstructured":"Schreier B, Wolf A, Hammer S, Pohl S, Mildenberger S, Rabe S, et al. The selective mineralocorticoid receptor antagonist eplerenone prevents decompensation of the liver in cirrhosis. Br J Pharmacol. 2018;175(14):2956\u201367.","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"1991_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2003.10.009","volume":"217","author":"B Pitt","year":"2004","unstructured":"Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol. 2004;217(1\u20132):53\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"1991_CR18","first-page":"875","volume":"25","author":"T Matono","year":"2010","unstructured":"Matono T, Koda M, Tokunaga S, Sugihara T, Ueki M, Murawaki Y. The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat. Int J Mol Med. 2010;25(6):875\u201382.","journal-title":"Int J Mol Med"},{"issue":"3","key":"1991_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.taap.2014.08.029","volume":"280","author":"N Queisser","year":"2014","unstructured":"Queisser N, Happ K, Link S, Jahn D, Zimnol A, Geier A, et al. Aldosterone induces fibrosis, oxidative stress and DNA damage in livers of male rats independent of blood pressure changes. Toxicol Appl Pharmacol. 2014;280(3):399\u2013407.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"13","key":"1991_CR20","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1111\/bph.15719","volume":"179","author":"D Clarisse","year":"2022","unstructured":"Clarisse D, Deng L, de Bosscher K, Lother A. Approaches towards tissue-selective pharmacology of the mineralocorticoid receptor. Br J Pharmacol. 2022;179(13):3235\u201349.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1991_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","volume":"18","author":"GK Michalopoulos","year":"2021","unstructured":"Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nat Rev Gastroenterol Hepatol. 2021;18(1):40\u201355.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1\u20132","key":"1991_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.mce.2003.10.045","volume":"217","author":"D Le Menuet","year":"2004","unstructured":"Le Menuet D, Viengchareun S, Muffat-Joly M, Zennaro M-C, Lomb\u00e8s M. Expression and function of the human mineralocorticoid receptor: lessons from transgenic mouse models. Mol Cell Endocrinol. 2004;217(1\u20132):127\u201336.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"1991_CR23","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1210\/endo.133.5.8404687","volume":"133","author":"SP Kwak","year":"1993","unstructured":"Kwak SP, Patel PD, Thompson RC, Akil H, Watson SJ. 5\u2019-Heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinology. 1993;133(5):2344\u201350.","journal-title":"Endocrinology"},{"key":"1991_CR24","doi-asserted-by":"crossref","unstructured":"Foglia B, Novo E, Protopapa F, Maggiora M, Bocca C, Cannito S et al. Hypoxia, hypoxia-inducible factors and liver fibrosis. Cells 2021; 10(7).","DOI":"10.3390\/cells10071764"},{"issue":"1","key":"1991_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12967-021-02854-x","volume":"19","author":"J Cai","year":"2021","unstructured":"Cai J, Hu M, Chen Z, Ling Z. The roles and mechanisms of hypoxia in liver fibrosis. J Transl Med. 2021;19(1):186.","journal-title":"J Transl Med"},{"issue":"7","key":"1991_CR26","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","volume":"160","author":"JC McGrath","year":"2010","unstructured":"McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol. 2010;160(7):1573\u20136.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1991_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/BF01609080","volume":"38","author":"T Sakata","year":"1987","unstructured":"Sakata T, Watanabe A, Hobara N, Nagashima H. Chronic liver injury in rats by carbon tetrachloride inhalation. Bull Environ Contam Toxicol. 1987;38(6):959\u201361.","journal-title":"Bull Environ Contam Toxicol"},{"issue":"5","key":"1991_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jhep.2008.06.027","volume":"49","author":"A Zipprich","year":"2008","unstructured":"Zipprich A, Loureiro-Silva MR, Jain D, D\u2019Silva I, Groszmann RJ. Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver. J Hepatol. 2008;49(5):739\u201345.","journal-title":"J Hepatol"},{"issue":"6","key":"1991_CR29","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/0016-5085(93)90655-V","volume":"104","author":"CC Sieber","year":"1993","unstructured":"Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology. 1993;104(6):1750\u20134.","journal-title":"Gastroenterology"},{"issue":"3","key":"1991_CR30","doi-asserted-by":"publisher","first-page":"e0121229","DOI":"10.1371\/journal.pone.0121229","volume":"10","author":"M Moeller","year":"2015","unstructured":"Moeller M, Thonig A, Pohl S, Ripoll C, Zipprich A. Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis. PLoS ONE. 2015;10(3):e0121229.","journal-title":"PLoS ONE"},{"issue":"41","key":"1991_CR31","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.3748\/wjg.v12.i41.6577","volume":"12","author":"J-G Abraldes","year":"2006","unstructured":"Abraldes J-G, Pasar\u00edn M, Garc\u00eda-Pag\u00e1n J-C. Animal models of portal hypertension. World J Gastroenterol. 2006;12(41):6577\u201384.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1991_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0003-2697(87)90673-7","volume":"161","author":"SL Friedman","year":"1987","unstructured":"Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem. 1987;161(1):207\u201318.","journal-title":"Anal Biochem"},{"issue":"4","key":"1991_CR33","doi-asserted-by":"publisher","first-page":"G763","DOI":"10.1152\/ajpgi.00300.2004","volume":"288","author":"M Graupera","year":"2005","unstructured":"Graupera M, March S, Engel P, Rod\u00e9s J, Bosch J, Garc\u00eda-Pag\u00e1n J-C. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. Am J Physiol Gastrointest Liver Physiol. 2005;288(4):G763\u201370.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1991_CR34","doi-asserted-by":"crossref","unstructured":"Dubourg V, Schreier B, Schwerdt G, Rabe S, Benndorf RA, Gekle M. The Functional Interaction of EGFR with AT1R or TP in primary vascular smooth muscle cells triggers a synergistic regulation of Gene expression. Cells 2022; 11(12).","DOI":"10.3390\/cells11121936"},{"issue":"8","key":"1991_CR35","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907\u201315.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"1991_CR36","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"issue":"8","key":"1991_CR37","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc. 2009;4(8):1184\u201391.","journal-title":"Nat Protoc"},{"issue":"1","key":"1991_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"12","key":"1991_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"W1","key":"1991_CR40","doi-asserted-by":"publisher","first-page":"W83","DOI":"10.1093\/nar\/gkw199","volume":"44","author":"J Reimand","year":"2016","unstructured":"Reimand J, Arak T, Adler P, Kolberg L, Reisberg S, Peterson H, et al. G:Profiler-a web server for functional interpretation of gene lists (2016 update). Nucleic Acids Res. 2016;44(W1):W83\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1991_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/bioinformatics\/btn615","volume":"25","author":"S Carbon","year":"2009","unstructured":"Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S, et al. AmiGO: online access to ontology and annotation data. Bioinformatics. 2009;25(2):288\u20139.","journal-title":"Bioinformatics"},{"issue":"7","key":"1991_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3727\/000000005783982855","volume":"14","author":"H Aurich","year":"2005","unstructured":"Aurich H, Koenig S, Schneider C, Walldorf J, Krause P, Fleig WE, et al. Functional characterization of serum-free cultured rat hepatocytes for downstream transplantation applications. Cell Transpl. 2005;14(7):497\u2013506.","journal-title":"Cell Transpl"},{"issue":"14","key":"1991_CR43","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.steroids.2011.09.004","volume":"76","author":"CE Gomez-Sanchez","year":"2011","unstructured":"Gomez-Sanchez CE, Warden M, Gomez-Sanchez MT, Hou X, Gomez-Sanchez EP. Diverse immunostaining patterns of mineralocorticoid receptor monoclonal antibodies. Steroids. 2011;76(14):1541\u20135.","journal-title":"Steroids"},{"key":"1991_CR44","doi-asserted-by":"crossref","unstructured":"Schwerdt G, Kopf M, Gekle M. The nephrotoxin ochratoxin a impairs resilience of energy homeostasis of human proximal tubule cells. Mycotoxin Res 2023; 39(4):393\u2013403.","DOI":"10.1007\/s12550-023-00500-7"},{"issue":"4","key":"1991_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/21623945.2016.1240137","volume":"5","author":"NA Kraus","year":"2016","unstructured":"Kraus NA, Ehebauer F, Zapp B, Rudolphi B, Kraus BJ, Kraus D. Quantitative assessment of adipocyte differentiation in cell culture. Adipocyte. 2016;5(4):351\u20138.","journal-title":"Adipocyte"},{"key":"1991_CR46","doi-asserted-by":"publisher","first-page":"33999","DOI":"10.1038\/srep33999","volume":"6","author":"JS Sadick","year":"2016","unstructured":"Sadick JS, Boutin ME, Hoffman-Kim D, Darling EM. Protein characterization of intracellular target-sorted, formalin-fixed cell subpopulations. Sci Rep. 2016;6:33999.","journal-title":"Sci Rep"},{"key":"1991_CR47","volume-title":"Methoden Der Enzymatischen analyse","author":"HU Bergmeyer","year":"1974","unstructured":"Bergmeyer HU. Methoden Der Enzymatischen analyse. Verlag Chemie: Weinheim; 1974."},{"key":"1991_CR48","doi-asserted-by":"crossref","unstructured":"Zhang C, Li H, Xiong Y, Chang Y, Yang F, Ma X et al. Chronic intermittent hypoxia induces renal fibrosis through MR activation. Exp Gerontol. 2022; 163:111780. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0531556522000882","DOI":"10.1016\/j.exger.2022.111780"},{"issue":"10","key":"1991_CR49","doi-asserted-by":"publisher","first-page":"L678","DOI":"10.1152\/ajplung.00300.2012","volume":"304","author":"IR Preston","year":"2013","unstructured":"Preston IR, Sagliani KD, Warburton RR, Hill NS, Fanburg BL, Jaffe IZ. Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2013;304(10):L678\u201388.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1991_CR50","doi-asserted-by":"crossref","unstructured":"Gaudenzi C, Mifsud KR, Reul, Johannes MHM. Insights into isoform-specific mineralocorticoid receptor action in the hippocampus. Journal of Endocrinology. 2023; 258(2):e220293. Available from: URL: https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/258\/2\/JOE-22-0293.xml","DOI":"10.1530\/JOE-22-0293"},{"key":"1991_CR51","doi-asserted-by":"publisher","unstructured":"Gadasheva Y, Nolze A, Grossmann C. Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging. Front Mol Biosci. 2021; 8. Available from: URL: https:\/\/www.frontiersin.org\/journals\/molecular-biosciences\/articles\/https:\/\/doi.org\/10.3389\/fmolb.2021.667990","DOI":"10.3389\/fmolb.2021.667990"},{"key":"1991_CR52","doi-asserted-by":"crossref","unstructured":"Tomkins GM, ENZYMATIC METABOLISM OF CORTICOSTEROIDS. Ann N Y Acad Sci. 1959;82(4):836\u201345.","DOI":"10.1111\/j.1749-6632.1960.tb44965.x"},{"issue":"7\u201308","key":"1991_CR53","first-page":"386","volume":"131","author":"CE Gomez-Sanchez","year":"2023","unstructured":"Gomez-Sanchez CE, Gomez-Sanchez EP. An abbreviated history of Aldosterone Metabolism, Current and Future challenges. Exp Clin Endocrinol Diabetes. 2023;131(7\u201308):386\u201393.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"1991_CR54","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1210\/en.2009-0869","volume":"151","author":"T Wada","year":"2010","unstructured":"Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, et al. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology. 2010;151(5):2040\u20139.","journal-title":"Endocrinology"},{"issue":"5","key":"1991_CR55","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/hep.1840190506","volume":"19","author":"JC Garc\u00eda-Pag\u00e1n","year":"1994","unstructured":"Garc\u00eda-Pag\u00e1n JC, Salmer\u00f3n JM, Feu F, Luca A, Gin\u00e9s P, Pizcueta P, et al. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. Hepatology. 1994;19(5):1095\u20139.","journal-title":"Hepatology"},{"issue":"2","key":"1991_CR56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jhep.2010.03.013","volume":"53","author":"P Tandon","year":"2010","unstructured":"Tandon P, Abraldes JG, Berzigotti A, Garcia-Pagan JC, Bosch J. Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis. J Hepatol. 2010;53(2):273\u201382.","journal-title":"J Hepatol"},{"issue":"3","key":"1991_CR57","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1002\/wsbm.1474","volume":"12","author":"M Certo","year":"2020","unstructured":"Certo M, Marone G, de Paulis A, Mauro C, Pucino V. Lactate: fueling the fire starter. Wiley Interdiscip Rev Syst Biol Med. 2020;12(3):e1474.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"6","key":"1991_CR58","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1742-4658.2008.06290.x","volume":"275","author":"MD Lloyd","year":"2008","unstructured":"Lloyd MD, Darley DJ, Wierzbicki AS, Threadgill MD. Alpha-methylacyl-CoA racemase\u2014an \u2018obscure\u2019 metabolic enzyme takes centre stage. FEBS J. 2008;275(6):1089\u2013102.","journal-title":"FEBS J"},{"issue":"5","key":"1991_CR59","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0163-7827(03)00016-X","volume":"42","author":"M Mukherji","year":"2003","unstructured":"Mukherji M, Schofield CJ, Wierzbicki AS, Jansen GA, Wanders RJA, Lloyd MD. The chemical biology of branched-chain lipid metabolism. Prog Lipid Res. 2003;42(5):359\u201376.","journal-title":"Prog Lipid Res"},{"key":"1991_CR60","doi-asserted-by":"crossref","unstructured":"Cave MC, Clair HB, Hardesty JE, Falkner KC, Feng W, Clark BJ et al. Nuclear receptors and nonalcoholic fatty liver disease11This article is part of a Special Issue entitled: Xenobiotic nuclear receptors: New Tricks for An Old Dog, edited by Dr. Wen Xie. Biochim Biophys Acta Gene Regul Mech. 2016; 1859(9):1083\u201399. Available from: URL: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1874939916300414","DOI":"10.1016\/j.bbagrm.2016.03.002"},{"issue":"3","key":"1991_CR61","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","volume":"62","author":"M Pawlak","year":"2015","unstructured":"Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J Hepatol. 2015;62(3):720\u201333.","journal-title":"J Hepatol"},{"issue":"3","key":"1991_CR62","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1159\/000447796","volume":"39","author":"M Wang","year":"2016","unstructured":"Wang M, Li Y, Zhou K, Zhang G, Wang Y, Liu T, et al. Mineralocorticoid receptor blockade improves insulin sensitivity in the Rat Heart and a possible molecular mechanism. Cell Physiol Biochem. 2016;39(3):860\u201370.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"1991_CR63","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.HYP.0000083511.91817.B1","volume":"42","author":"M Iglarz","year":"2003","unstructured":"Iglarz M, Touyz RM, Viel EC, Paradis P, Amiri F, Diep QN, et al. Peroxisome proliferator-activated Receptor-\u03b1 and Receptor-\u03b3 activators prevent Cardiac Fibrosis in Mineralocorticoid-Dependent Hypertension. Hypertension. 2003;42(4):737\u201343.","journal-title":"Hypertension"},{"issue":"40","key":"1991_CR64","doi-asserted-by":"publisher","first-page":"24527","DOI":"10.1016\/S0021-9258(17)31420-5","volume":"269","author":"T Lemberger","year":"1994","unstructured":"Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J, Wahli W. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J Biol Chem. 1994;269(40):24527\u201330.","journal-title":"J Biol Chem"},{"issue":"3","key":"1991_CR65","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/13813450600935263","volume":"112","author":"MC Sugden","year":"2006","unstructured":"Sugden MC, Holness MJ. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem. 2006;112(3):139\u201349.","journal-title":"Arch Physiol Biochem"},{"issue":"2","key":"1991_CR66","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2337\/diabetes.51.2.276","volume":"51","author":"B Huang","year":"2002","unstructured":"Huang B, Wu P, Bowker-Kinley MM, Harris RA. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes. 2002;51(2):276\u201383.","journal-title":"Diabetes"},{"issue":"8","key":"1991_CR67","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm898","volume":"9","author":"C Bernal-Mizrachi","year":"2003","unstructured":"Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, Leone TC, et al. Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med. 2003;9(8):1069\u201375.","journal-title":"Nat Med"},{"issue":"4","key":"1991_CR68","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/cphy.c130001","volume":"3","author":"DQ-H Wang","year":"2013","unstructured":"Wang DQ-H, Portincasa P, Neuschwander-Tetri BA. Steatosis in the liver. Compr Physiol. 2013;3(4):1493\u2013532.","journal-title":"Compr Physiol"},{"key":"1991_CR69","doi-asserted-by":"crossref","unstructured":"Di Ciaula A, Passarella S, Shanmugam H, Noviello M, Bonfrate L, Wang DQ-H et al. Nonalcoholic fatty liver Disease (NAFLD). Mitochondria as players and targets of therapies? Int J Mol Sci 2021; 22(10).","DOI":"10.3390\/ijms22105375"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01991-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01991-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T12:03:29Z","timestamp":1734696209000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01991-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01991-2","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the german law and the directive 2010\/63\/EU. They were ethically and legally approved by the governmental, local animal committees (42502-2-1123 MLU, Landesverwaltungsamt Sachsen-Anhalt or TWZ 16-2021, Jena University hospital). All animal studies were conducted in compliance with the ARRIVE guidelines and the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"614"}}